INTERPACE BIOSCIENCES, INC. (IDXG) Return on equity 2017–2025
INTERPACE BIOSCIENCES, INC. (IDXG) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
109.9%FY2025 · since FY2017: 54.8% → 109.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 109.9% | — |
| FY2018 | -82.2% | -137.1 pp |
| FY2017 | 54.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More IDXG financial trends
IDXG RevenueIDXG Net incomeIDXG Net marginIDXG Gross profitIDXG Gross marginIDXG Operating incomeIDXG Operating marginIDXG Operating cash flowIDXG Free cash flowIDXG Capital expendituresIDXG Stock buybacksIDXG Dividends paidIDXG Total assetsIDXG Total liabilitiesIDXG Shareholders’ equityIDXG overview →